I. Tomaszewska

In vitro and Physiologically Based Pharmacokinetic models for pharmaceutical cocrystals Irena Tomaszewska

I. Tomaszewska, 2013 .

In vitro simulation of the environment in the upper gastrointestinal lumen after drug administration in the fed state using the TIM-1 system and comparison with luminal data in adults.

M. Minekus, S. Bellmann, C. Reppas, 2021, Journal of pharmaceutical sciences.

Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended release nifedipine.

J. Dressman, W. Mueck, U. Muenster, 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Dissolution Testing of Poorly Soluble Drugs: “Biorelevant Dissolution”

M. McAllister, I. Tomaszewska, 2017 .

Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.

N. Fotaki, R. Price, S. Karki, 2013, International journal of pharmaceutics.

Biorelevant dissolution testing of a weak base: Interlaboratory reproducibility and investigation of parameters controlling in vitro precipitation.

J. Dressman, P. Augustijns, J. Butler, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Validation of Dissolution Testing with Biorelevant Media: An OrBiTo Study.

Patrick Augustijns, René Holm, Paul Hutchins, 2017, Molecular pharmaceutics.

Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An In Vivo–In Vitro–In Silico Approach

B. Hens, M. McAllister, L. Wollenberg, 2023, Molecular pharmaceutics.

Validation of Dissolution Testing with Biorelevant Media: An OrBiTo Study.

J. Dressman, P. Augustijns, R. Holm, 2017, Molecular pharmaceutics.

Investigating the Impact of Crohn's Disease on the Bioaccessibility of a Lipid-Based Formulation with an In Vitro Dynamic Gastrointestinal Model.

C. O’Driscoll, N. Fotaki, M. McAllister, 2021, Molecular pharmaceutics.

Stimuli to the Revision Process: The Case for Apex Vessels

Julian S. Williams, B. Abrahamsson, B. Nickerson, 2021, Dissolution Technologies.